Effects of Absorption with Pneumococcal Type 22F Polysaccharide on Maternal, Cord Blood, and Infant Immunoglobulin G Antipneumococcal Polysaccharide Antibodies
- 1 June 2005
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 12 (6) , 722-6
- https://doi.org/10.1128/cdli.12.6.722-726.2005
Abstract
The aim of this study was to evaluate the effect of absorption with pneumococcal type 22F polysaccharide on antipneumococcal antibody titers in unimmunized Chilean pregnant women and on antibodies in their offspring at birth and 3, 6, and 12 months of age. Sera from 10 healthy pregnant women and from their offspring at birth and at 3, 6, and 12 months of age were studied. Immunoglobulin G antibodies against serotypes 1, 3, 4, 5, 6B, 9V, 14, 18, 19F, and 23F were measured by a standardized enzyme-linked immunosorbent assay method. All sera were absorbed with polysaccharide C, and aliquots of each serum were absorbed with polysaccharide 22F. Individual results were expressed in μg/ml based on the standard serum pool 89-SF. Absorption with polysaccharide 22F reduced antibody concentrations in all samples and to all 10 serotypes studied. Reduction was highest in maternal sera and in cord blood, but it was also present at 3, 6, and 12 months of age. The percent reduction ranged from 24% for serotype 14 to 50% for serotype 1 in maternal samples and from 20% for serotype 18C to 49% for serotype 4 in cord blood samples. The percentages of transplacental transmission were similar for nonabsorbed and absorbed maternal fetal pairs. Absorption with serotype 22F had a significant impact on antipneumococcal antibody concentrations in unimmunized pregnant women and in their offspring. Our results suggest that absorption with 22F polysaccharide needs to be performed in studies of transplacental transmission of antipneumococcal antibodies.Keywords
This publication has 21 references indexed in Scilit:
- Specificity of the Antibody Response to the Pneumococcal Polysaccharide and Conjugate Vaccines in Human Immunodeficiency Virus-Infected AdultsClinical and Vaccine Immunology, 2004
- Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal PolysaccharidesClinical and Vaccine Immunology, 2003
- Specificities and Opsonophagocytic Activities of Antibodies to Pneumococcal Capsular Polysaccharides in Sera of Unimmunized Young ChildrenClinical and Vaccine Immunology, 2002
- Natural Development of Antibodies to Pneumococcal Capsular Polysaccharides Depends on the Serotype: Association with Pneumococcal Carriage and Acute Otitis Media in Young ChildrenThe Journal of Infectious Diseases, 2001
- Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent AssayClinical and Diagnostic Laboratory Immunology, 2001
- Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniaeClinical and Experimental Immunology, 1999
- Immunity to Cross‐Reactive Serotypes Induced by Pneumococcal Conjugate Vaccines in InfantsThe Journal of Infectious Diseases, 1999
- Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancyVaccine, 1996
- Serum antibodies to pneumococcal C polysaccharide in childrenThe Pediatric Infectious Disease Journal, 1987
- Maternal-Fetal Transfer of Pneumococcal Capsular Polysaccharide AntibodiesArchives of Pediatrics & Adolescent Medicine, 1985